Showing results (1111-1120 of 1,166) with videos related to

Sort By:
Pageof 117
Global Heart|December 13, 2021
Cardiogenic Shock Among Patients with and without Acute Myocardial Infarction in a Latin American Country: A Single-Institution StudyHéctor González-Pacheco, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2015
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-βMarta F Bustamante, Carlos Morcillo-Suárez, Sunny Malhotra, et al.
Rheumatology International|February 9, 2018
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in SpainJordi Gratacós, Jesús Luelmo, Jesús Rodríguez, et al.
Nature Medicine|August 8, 2018
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potentialAdam B Roberts, Xiaodong Gu, Jennifer A Buffa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 24, 2025
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort studyIgor Gomez-Randulfe, Federico Monaca, Ornella Cantale, et al.
Journal of Nephrology|March 31, 2022
Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable methodRosa Miquel Rodríguez, Sergio Luis-Lima, Juan Manuel Fernandez, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 14, 2016
Overactive bladder - 18 years - Part IJose Carlos Truzzi, Cristiano Mendes Gomes, Carlos A Bezerra, et al.
Circulation|November 3, 2016
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular DamageThiago Bruder-Nascimento, Nathanne S Ferreira, Camila Z Zanotto, et al.
Scientific Reports|March 15, 2025
Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumabLorena Incorvaia, Sarah Scagliarini, Fernando Sabino Marques Monteiro, et al.
Frontiers in Molecular Biosciences|May 9, 2024
Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK ProjectAna Peixoto, Luís Cirnes, Ana Luísa Carvalho, et al.
Pageof 117